Selank does not directly bind classical neurotransmitter receptors but instead modulates receptor expression and function through gene regulation. It influences GABA-A receptor subunit composition, alters opioid peptide metabolism, and affects 5-HT receptor sensitivity.
Receptor binding studies show Selank's anxiolytic effects occur through indirect modulation of multiple neurotransmitter systems rather than direct receptor agonism.